Magnesium-zinc-calcium alloy and method for producing implants containing the same

Patent metadata

Field	Value
Publication number	US-11499214-B2
Application number	US-201916422025-A
Country	US
Kind code	B2
Filing date	May 24, 2019
Priority date	Jun 26, 2012
Publication date	Nov 15, 2022
Grant date	Nov 15, 2022

Abstract

A magnesium alloy includes <3% by weight of Zn, ≤0.6% by weight of Ca, with the rest being formed by magnesium containing impurities, which favor electrochemical potential differences and/or promote the formation of intermetallic phases, in a total amount of no more than 0.005% by weight of Fe, Si, Mn, Co, Ni, Cu, Al, Zr and P, wherein the alloy contains elements selected from the group of rare earths with the atomic number 21, 39, 57 to 71 and 89 to 103 in a total amount of no more than 0.002% by weight.

First claim

The invention claimed is:

1. A method for producing a biodegradable implant comprising a magnesium alloy comprising an alloy matrix, the alloy having improved mechanical and electrochemical properties, comprising:
a) producing a highly pure magnesium by means of vacuum distillation;
b) producing a cast billet of the alloy by means of synthesis of the magnesium with a composition comprising no more than 3% by weight of Zn, no more than 0.6% by weight of Ca, with the rest being formed by magnesium containing impurities, which favor electrochemical potential differences and/or promote the formation of intermetallic phases, in a total amount of no more than 0.007% by weight of Fe, Si, Mn, Co, Ni, Cu, Al, Zr and P, and elements selected from the group of rare earths with the atomic number 21, 39, 57 to 71 and 89 to 103;
c) homogenizing the alloy to bring the alloy constituents into complete solution by annealing in one or more annealing steps at one or more successively increasing temperatures between 300° C. and 450° C.;
d) forming the homogenized alloy in a temperature range between 150° C. and 375° C.,
wherein phases Ca 2 Mg 6 Zn 3 and/or Mg 2 Ca are precipitated out before, during and/or after the forming process, and
wherein the Ca 2 Mg 6 Zn 3 and/or Mg 2 Ca precipitates have a size of <2.0 μm, and, in a fine-grain structure with a grain size of no more than 5.0 μm, are distributed dispersely at the grain boundaries and in the grain.

2. The method of claim 1 , wherein said phases are less noble than the alloy matrix and the potential difference existing between the alloy matrix and the Ca 2 Mg 6 Zn 3 and/or Mg 2 Ca precipitates are used to set the degradation rate of the alloy matrix.

3. The method of claim 1 , wherein grain refinement during the forming process is produced by the phases Ca 2 Mg 6 Zn 3 and/or Mg 2 Ca instead of the Zr particles or the particles containing Zr.

4. The method of claim 1 , wherein each of the one or more annealing steps further comprises a holding period of between 0.5 h and 40 h.

5. The method of claim 1 , further comprising ageing the homogenized alloy at a temperature of between 100° C. and 450° C.

6. The method of claim 5 , wherein the homogenized alloy is aged for a period of time of between 0.5 h and 20 h.

7. The method of claim 1 , further comprising ageing the formed homogenized alloy at a temperature of between 100° C. and 450° C.

8. The method of claim 7 , wherein the formed homogenized alloy is aged for a period of time of between 0.5 h and 20 h.

9. The method of claim 1 , further comprising carrying out a heat treatment of the formed homogenized alloy at a temperature of between 100° C. and 325° C.

10. The method of claim 9 , wherein the heat treatment further comprises a holding period of between 1 min and 10 h.

Assignees

• Biotronik Ag

Inventors

• Mueller Heinz
• Uggowitzer Peter
• Loeffler Joerg

Classifications

• C22F1/06 Primary

  of magnesium or alloys based thereon · CPC title

• C22C23/04

  with zinc or cadmium as the next major constituent · CPC title